These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4187354)

  • 1. Sleep EEG patterns in a case of Down's syndrome--before and after 5-HTP.
    Lee JC; Ornitz EM; Tanguay PE; Ritvo ER
    Electroencephalogr Clin Neurophysiol; 1969 Sep; 27(7):686. PubMed ID: 4187354
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Hydroxytryptophan and sleep in Down's syndrome.
    Petre-Quadens O; De Lee C
    J Neurol Sci; 1975 Nov; 26(3):443-53. PubMed ID: 171348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of high doses of 5-hydroxytryptophan on a patient with trisomy 21. Clinical, chemical and EEG correlations.
    Bazelon M; Barnet A; Lodge A; Shelburne SA
    Brain Res; 1968 Nov; 11(2):397-411. PubMed ID: 4302675
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-hydroxytryptophan (5-HTP) in Down's syndrome.
    Partington MW; MacDonald MR
    Dev Med Child Neurol; 1971 Jun; 13(3):362-72. PubMed ID: 4255254
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of 5-HTP in the treatment of Down's syndrome.
    Weise P; Koch R; Shaw KN; Rosenfeld MJ
    Pediatrics; 1974 Aug; 54(2):165-8. PubMed ID: 4277102
    [No Abstract]   [Full Text] [Related]  

  • 6. Infantile spasms associated with 5-hydroxytryptophan administration in patients with Down's syndrome.
    Coleman M
    Neurology; 1971 Sep; 21(9):911-9. PubMed ID: 4328302
    [No Abstract]   [Full Text] [Related]  

  • 7. Sleep patterns of Down's syndrome children: effects of butoctamide hydrogen succinate (BAHS) administration.
    Grubar JC; Gigli GL; Colognola RM; Ferri R; Musumeci SA; Bergonzi P
    Psychopharmacology (Berl); 1986; 90(1):119-22. PubMed ID: 2945221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Down's syndrome and serotonin].
    Oura T; Uemura I
    Saishin Igaku; 1968 Feb; 24(2):328-31. PubMed ID: 4239279
    [No Abstract]   [Full Text] [Related]  

  • 9. EEG evoked responses to repetitive auditory stimulation in normal and Down's syndrome infants.
    Barnet AB; Ohlrich ES; Shanks BL
    Dev Med Child Neurol; 1971 Jun; 13(3):321-9. PubMed ID: 4255253
    [No Abstract]   [Full Text] [Related]  

  • 10. Sleep patterns in mental retardation: Down's syndrome.
    Clausen J; Sersen EA; Lidsky A
    Electroencephalogr Clin Neurophysiol; 1977 Aug; 43(2):183-91. PubMed ID: 69529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of hypotonia in infants with Down's syndrome by administration of 5-hydroxytryptophan.
    Bazelon M; Paine RS; Coeiw VA; Hunt P; Houck JC; Mahanand D
    Lancet; 1967 May; 1(7500):1130-3. PubMed ID: 4164790
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy with 5-hydroxytryptophan of Down's disease].
    Simonsson H
    Nord Med; 1969 Jul; 81(31):952-4. PubMed ID: 4241288
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of 5-HTP on sleep in Mongol children. Preliminary results.
    Petre-Quadens O; De Greef A
    J Neurol Sci; 1971 May; 13(1):115-9. PubMed ID: 4327739
    [No Abstract]   [Full Text] [Related]  

  • 14. Butoctamide hydrogen succinate and intensive learning sessions: effects on night sleep of Down's syndrome patients.
    Gigli GL; Grubar JC; Colognola RM; Amata MT; Pollicina C; Ferri R; Musumeci SA; Bergonzi P
    Sleep; 1987 Dec; 10(6):563-9. PubMed ID: 2963363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal treatment for relief of hypotonia in Down's Syndrome.
    Griffiths MI
    Physiotherapy; 1976 Jan; 62(1):19-20. PubMed ID: 130644
    [No Abstract]   [Full Text] [Related]  

  • 16. Polygraphic study on the nocturnal sleep of children with Down's syndrome and endogenous mental retardation.
    Fukuma E; Umezawa Y; Kobayashi K; Motoike M
    Folia Psychiatr Neurol Jpn; 1974; 28(4):333-45. PubMed ID: 4375652
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of EEG and daytime sleep patterns in Trisomy-21 infants during the first year of life: longitudinal observations.
    Ellingson RJ; Peters JF
    Electroencephalogr Clin Neurophysiol; 1980 Dec; 50(5-6):457-66. PubMed ID: 6160988
    [No Abstract]   [Full Text] [Related]  

  • 18. Review of drug treatment for Down's syndrome persons.
    Share JB
    Am J Ment Defic; 1976 Jan; 80(4):388-93. PubMed ID: 2011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life span changes in the averaged evoked responses of Down's syndrome and nonretarded persons.
    Callner DA; Dustman RE; Madsen JA; Schenkenberg T; Beck EC
    Am J Ment Defic; 1978 Jan; 82(4):398-405. PubMed ID: 146432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Click evoked EEG responses in normal and developmentally retarded infants.
    Barnet AB; Lodge A
    Nature; 1967 Apr; 214(5085):252-5. PubMed ID: 4226768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.